Luke Maese
Pediatric Hematology-Oncology · Salt Lake City, UTNPI 1154553469
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 95.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $95,929 and has fallen 52.6% since, to $45,458 in 2025. Among pediatric hematology-oncology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $1332.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$317K
- Servier Pharmaceuticals LLC$10K
- Syndax Pharmaceuticals, Inc.$2K
- Genentech, Inc.$2K
- F. Hoffmann-la Roche AG$1K
Across 175 payments — averaging $5209.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$363K
- Genentech, Inc.$241K
- Novartis$89K
- Janssen Research & Development, LLC$85K
- F. Hoffmann-la Roche AG$80K
- AbbVie$42K
- plus $13K from 3 others
What the payments were for
- Consulting fees$110,24033%
- Speaking & faculty fees$157,89848%
- Travel & lodging$56,64617%
- Food & beverage$6,8232%
- Education$2400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 226 | $317,144 |
| Servier Pharmaceuticals LLC | 8 | $9,937 |
| Syndax Pharmaceuticals, Inc. | 2 | $1,784 |
| Genentech, Inc. | 8 | $1,668 |
| F. Hoffmann-la Roche AG | 5 | $1,314 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$331,846 in reported general payments places this provider in the 95th percentile of 24 pediatric hematology-oncology providers in Utah.
Other pediatric hematology-oncology in Salt Lake City
- Richard LemonsSalt Lake City$753K
- Hassan YaishSalt Lake City$113K
- Julie AschSalt Lake City$62K
- Ahmad RayesSalt Lake City$5K
- Nicholas WhippleSalt Lake City$3K
- Michell Lozano ChingaSalt Lake City$1K
- Soohee ChoSalt Lake City$948
- Joseph DolanSalt Lake City$295
- Mark FluchelSalt Lake City$235
- Elaine FanSalt Lake City$229
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.